- Home
- SBFM vs TTNP Comparison
SBFM vs TTNP Comparison
Compare SBFM & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- TTNP
- Stock Information
- Founded
- SBFM 2006
- TTNP 1991
- Country
- SBFM United States
- TTNP United States
- Employees
- SBFM N/A
- TTNP N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBFM Health Care
- TTNP Health Care
- Exchange
- SBFM Nasdaq
- TTNP Nasdaq
- Market Cap
- SBFM 6.5M
- TTNP 5.4M
- IPO Year
- SBFM N/A
- TTNP 1996
- Fundamental
- Price
- SBFM $1.49
- TTNP $4.93
- Analyst Decision
- SBFM Strong Buy
- TTNP
- Analyst Count
- SBFM 1
- TTNP 0
- Target Price
- SBFM $15.00
- TTNP N/A
- AVG Volume (30 Days)
- SBFM 54.6K
- TTNP 49.3K
- Earning Date
- SBFM 08-12-2025
- TTNP 08-26-2025
- Dividend Yield
- SBFM N/A
- TTNP N/A
- EPS Growth
- SBFM N/A
- TTNP N/A
- EPS
- SBFM N/A
- TTNP N/A
- Revenue
- SBFM $36,341,741.00
- TTNP N/A
- Revenue This Year
- SBFM $32.20
- TTNP N/A
- Revenue Next Year
- SBFM $32.74
- TTNP N/A
- P/E Ratio
- SBFM N/A
- TTNP N/A
- Revenue Growth
- SBFM 19.22
- TTNP N/A
- 52 Week Low
- SBFM $1.17
- TTNP $3.03
- 52 Week High
- SBFM $3.90
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SBFM 51.16
- TTNP 62.92
- Support Level
- SBFM $1.35
- TTNP $4.64
- Resistance Level
- SBFM $1.52
- TTNP $5.17
- Average True Range (ATR)
- SBFM 0.08
- TTNP 0.29
- MACD
- SBFM 0.01
- TTNP 0.11
- Stochastic Oscillator
- SBFM 66.30
- TTNP 83.67
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.